Literature DB >> 22716235

Design, facile synthesis, and antibacterial activity of hybrid 1,3,4-thiadiazole-1,3,5-triazine derivatives tethered via -S- bridge.

Vaibhav Dubey1, Manish Pathak, Hans R Bhat, Udaya P Singh.   

Abstract

Some hybrid 1,3,4-thiadiazole-1,3,5-triazine derivatives tethered via -S- bridge were synthesized and characterized with the aid of spectroscopic and elemental analysis. These hybrid conjugates were then investigated for their antibacterial activity against selected Gram-positive and Gram-negative bacteria. Excellent to moderate antibacterial activity was presented by the target compounds.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22716235     DOI: 10.1111/j.1747-0285.2012.01433.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  6 in total

1.  Anti‑breast cancer activity of selected 1,3,5‑triazines via modulation of EGFR‑TK.

Authors:  Weixin Yan; Yiyang Zhao; Jianrong He
Journal:  Mol Med Rep       Date:  2018-08-24       Impact factor: 2.952

2.  Design, Synthesis, and Biological Activity of Novel Myricetin Derivatives Containing Amide, Thioether, and 1,3,4-Thiadiazole Moieties.

Authors:  Xianghui Ruan; Cheng Zhang; Shichun Jiang; Tao Guo; Rongjiao Xia; Ying Chen; Xu Tang; Wei Xue
Journal:  Molecules       Date:  2018-11-29       Impact factor: 4.411

3.  Utilisation of Home Laundry Effluent (HLE) as a catalyst for expeditious one-pot aqueous phase synthesis of highly functionalised 4-thiazolidinones.

Authors:  Udaya Pratap Singh; Hans Raj Bhat; Mukesh Kumar Kumawat; Ramendra K Singh
Journal:  Springerplus       Date:  2013-09-16

4.  Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase.

Authors:  Jitendra Kumar Srivastava; Girinath G Pillai; Hans Raj Bhat; Amita Verma; Udaya Pratap Singh
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

Review 5.  The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies.

Authors:  R Frèdi Langendonk; Daniel R Neill; Joanne L Fothergill
Journal:  Front Cell Infect Microbiol       Date:  2021-04-16       Impact factor: 5.293

6.  Discovery of novel pyrazole derivatives as a potent anti-inflammatory agent in RAW264.7 cells via inhibition of NF-ĸB for possible benefit against SARS-CoV-2.

Authors:  Anup Masih; Amol K Agnihotri; Jitendra K Srivastava; Nidhi Pandey; Hans R Bhat; Udaya P Singh
Journal:  J Biochem Mol Toxicol       Date:  2020-10-23       Impact factor: 3.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.